What is the level of liabilities of Ipsen this year?
Ipsen has a debt balance of 2.5 B EUR this year.
Ipsen Liabilities 2024
Ipsen Liabilities
2.5 B EUR
Ipsen Dividend yield
1.01 %
Ticker
IPN.PA
ISIN
FR0010259150
WKN
A0ESMG
In 2024, Ipsen's total liabilities amounted to 2.5 B EUR, a 10% difference from the 2.27 B EUR total liabilities in the previous year.
Ipsen Aktienanalyse
What does Ipsen do?
Ipsen SA is a French biopharmaceutical company specialized in the development of drugs for the treatment of cancer, neurological disorders, and endocrine disorders. It was founded in 1929 by a pharmacist named Henri Beaufour and is headquartered in Paris. The history of Ipsen began with the production of extraction products from snake venom for the manufacturing of serum against tetanus and diphtheria. In the 1960s, the company started to focus on the production of hormones and peptides, with a focus on endocrine disorders. In the 1990s, Ipsen expanded its product portfolio to include oncology and neurological disorders. Ipsen's business model focuses on research and development of new drugs, as well as marketing of already established drugs in selected markets worldwide. The company employs around 5,700 employees and operates in more than 115 countries. Ipsen has two main business segments: specialty drugs and consumer healthcare. The specialty drugs segment focuses on the development and marketing of innovative therapies in the areas of oncology, endocrinology, and neuroscience. Ipsen's most well-known products include Somatuline, a drug for the treatment of acromegaly, and Decapeptyl, a drug for the treatment of prostate cancer and endometriosis. In the consumer healthcare segment, Ipsen is mainly specialized in the production of drugs for the treatment of gastrointestinal disorders and cold and flu symptoms. Some well-known brands include Smecta, a drug for diarrhea, and Nurofen, a pain reliever. Ipsen also has a strong presence in the field of aesthetic medicine, where the company operates a subsidiary called Ipsen Aesthetic. This subsidiary develops and markets products for the treatment of wrinkles and other signs of aging on the skin. Well-known brands of Ipsen Aesthetic include Dysport, a botulinum toxin product for the treatment of wrinkles, and the filler Restylane. Overall, Ipsen has established itself as a leading biopharmaceutical company focused on the development and marketing of products in specialized therapy areas. The company has a strong pipeline of new products in development and remains an important player in the pharmaceutical industry due to its strong scientific expertise and global presence. Ipsen ist eines der beliebtesten Unternehmen auf Eulerpool.com.Liabilities Details
Assessing Ipsen's Liabilities
Ipsen's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Ipsen's financial stability, operational efficiency, and long-term viability.
Year-to-Year Comparison
By comparing Ipsen's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Impact on Investments
Ipsen's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Interpreting Liability Fluctuations
Shifts in Ipsen’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Frequently Asked Questions about Ipsen Stock
What were the liabilities of Ipsen compared to the previous year?
The liabilities of Ipsen have increased by 10% increased compared to the previous year.
What are the consequences of high debt for investors of Ipsen?
High liabilities can pose a risk for investors of Ipsen, as they can weaken the company's financial position and impair its ability to meet its obligations.
What consequences do low liabilities have for investors in Ipsen?
Low liabilities mean that Ipsen has a strong financial position and is able to meet its obligations without overburdening its finances.
How does an increase in liabilities of Ipsen affect the company?
An increase in liabilities of Ipsen can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
How does a reduction in the liabilities of Ipsen affect the company?
A decrease in the liabilities of Ipsen can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
What are some factors that influence the liabilities of Ipsen?
Some factors that can influence the liabilities of Ipsen include investments, acquisitions, operating costs, and sales development.
Why is the level of liabilities of Ipsen so important for investors?
The liabilities of Ipsen are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
What strategic measures can Ipsen take to modify the liabilities?
To change its liabilities, Ipsen can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
How much dividend does Ipsen pay?
Over the past 12 months, Ipsen paid a dividend of 1.2 EUR . This corresponds to a dividend yield of about 1.01 %. For the coming 12 months, Ipsen is expected to pay a dividend of 1.4 EUR.
What is the dividend yield of Ipsen?
The current dividend yield of Ipsen is 1.01 %.
When does Ipsen pay dividends?
Ipsen pays a quarterly dividend. This is distributed in the months of June, June, July, June.
How secure is the dividend of Ipsen?
Ipsen paid dividends every year for the past 24 years.
What is the dividend of Ipsen?
For the upcoming 12 months, dividends amounting to 1.4 EUR are expected. This corresponds to a dividend yield of 1.18 %.
In which sector is Ipsen located?
Ipsen is assigned to the 'Health' sector.
Wann musste ich die Aktien von Ipsen kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Ipsen from 6/3/2024 amounting to 1.2 EUR, you needed to have the stock in your portfolio before the ex-date on 5/30/2024.
When did Ipsen pay the last dividend?
The last dividend was paid out on 6/3/2024.
What was the dividend of Ipsen in the year 2023?
In the year 2023, Ipsen distributed 1.2 EUR as dividends.
In which currency does Ipsen pay out the dividend?
The dividends of Ipsen are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Ipsen stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Ipsen
Our stock analysis for Ipsen Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ipsen Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
